506 related articles for article (PubMed ID: 27221282)
1. Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions.
Sun XK; Chen JF; Shen H
Arch Dermatol Res; 2016 Aug; 308(6):429-36. PubMed ID: 27221282
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of Toll-like receptors 1 and 2 expression in cutaneous lichen planus lesions.
Salem SA; Abu-Zeid RM; Nada OH
Arch Dermatol Res; 2013 Mar; 305(2):125-31. PubMed ID: 22842950
[TBL] [Abstract][Full Text] [Related]
3. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
Korman NJ; Stanley JR; Woodley DT
Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
[TBL] [Abstract][Full Text] [Related]
5. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
Sami N; Ahmed AR
Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid.
Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Aiba S
Dermatology; 2014; 229(4):369-78. PubMed ID: 25401296
[TBL] [Abstract][Full Text] [Related]
8. Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris.
Ergun EZ; Aoki R; Horváth ON; Hartmann D; Satoh TK; Calabrese L; Aksu AEK; Gürel MS; Manav V; Flaig MJ; Sárdy M; Ruzicka T; French LE; Bağcı IS
Exp Dermatol; 2023 Sep; 32(9):1412-1419. PubMed ID: 37260420
[TBL] [Abstract][Full Text] [Related]
9. A possible interaction between periostin and CD163
Fujimura T; Kakizaki A; Furudate S; Aiba S
Exp Dermatol; 2017 Dec; 26(12):1193-1198. PubMed ID: 27501402
[TBL] [Abstract][Full Text] [Related]
10. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
[TBL] [Abstract][Full Text] [Related]
11. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
[TBL] [Abstract][Full Text] [Related]
12. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid.
Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R
Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757
[TBL] [Abstract][Full Text] [Related]
13. Single-cell sequencing reveals distinct immune cell features in cutaneous lesions of pemphigus vulgaris and bullous pemphigoid.
Hu Z; Zheng M; Guo Z; Zhou W; Zhou W; Yao N; Zhang G; Lu Q; Zhao M
Clin Immunol; 2024 Jun; 263():110219. PubMed ID: 38631594
[TBL] [Abstract][Full Text] [Related]
14. [Expression of transient receptor potential lvanilloidreceptor 4 protein in autoimmune bullous skin disorders].
Bai J; Zou X; Jiang Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1349-51. PubMed ID: 26403753
[TBL] [Abstract][Full Text] [Related]
15. Lesional Th17 cells and regulatory T cells in bullous pemphigoid.
Arakawa M; Dainichi T; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Tsuruta D; Hashimoto T
Exp Dermatol; 2011 Dec; 20(12):1022-4. PubMed ID: 22017210
[TBL] [Abstract][Full Text] [Related]
16. Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid.
Grando SA; Glukhenky BT; Drannik GN; Kostromin AP; Boiko YYa ; Senyuk OF
Autoimmunity; 1989; 3(4):247-60. PubMed ID: 2491630
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of eccrine glands and hair follicles in direct immunofluorescent analysis of pemphigus vulgaris and bullous pemphigoid.
Zhou C; Yu Y; Elston DM
J Cutan Pathol; 2016 Apr; 43(4):334-8. PubMed ID: 26749398
[TBL] [Abstract][Full Text] [Related]
18. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
Alpsoy E; Akman-Karakas A; Uzun S
Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
[TBL] [Abstract][Full Text] [Related]
19. B-cell activating factor detected on both naïve and memory B cells in bullous pemphigoid.
Qian H; Kusuhara M; Li X; Tsuruta D; Tsuchisaka A; Ishii N; Koga H; Hayakawa T; Ohara K; Karashima T; Ohyama B; Ohata C; Furumura M; Hashimoto T
Exp Dermatol; 2014 Aug; 23(8):596-605. PubMed ID: 24758362
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
